Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.920
-0.060 (-1.51%)
Apr 23, 2026, 4:00 PM EDT - Market closed

Cellectis Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
79.5949.229.1925.7238.6
Revenue Growth (YoY)
61.72%435.38%-64.26%-33.35%-
Cost of Revenue
--0.741.771.84
Gross Profit
79.5949.228.4623.9536.75
Selling, General & Admin
19.7919.0916.8117.4922.88
Research & Development
93.5290.5487.6597.5117.84
Other Operating Expenses
0.640.85-1.31.380.49
Total Operating Expenses
113.95110.47103.16116.37141.21
Operating Income
-33.08-59.55-97.3-89.67-103.48
Interest Income
16.1244.4121.488.8813.22
Interest Expense
-51.06-21.61-40.64-17.82-6.49
Other Non-Operating Income (Expense)
-34.9422.79-19.16--
Total Non-Operating Income (Expense)
-69.8845.59-38.33-8.946.73
Pretax Income
-102.96-13.97-135.63-98.6-96.75
Provision for Income Taxes
0.420-0.37-0.09-
Net Income
-67.59-36.76-101.06-106.14-114.2
Minority Interest in Earnings
---7.38-7.89-10.91
Earnings From Discontinued Operations
--8.39-15.35-28.36
Net Income to Common
-67.59-36.76-101.06-106.14-114.2
Shares Outstanding (Basic)
10091574645
Shares Outstanding (Diluted)
10091574645
Shares Change (YoY)
10.72%58.85%25.17%1.62%-
EPS (Basic)
-0.67-0.41-1.77-2.33-2.55
EPS (Diluted)
-0.67-0.41-1.77-2.33-2.55
Shares Outstanding
100.34----
Free Cash Flow
-41.7620.41-25.82-89.88-123.11
Free Cash Flow Per Share
-0.420.23-0.45-1.97-2.75
Gross Margin
100.00%100.00%91.98%93.11%95.22%
Operating Margin
-41.56%-121.00%-1058.44%-348.57%-268.11%
Profit Margin
-84.92%-74.69%-1270.91%-383.64%-250.66%
FCF Margin
-52.47%41.46%-280.85%-349.38%-318.95%
EBITDA
-13.01-39.71-78.78-71.23-89.33
EBITDA Margin
-16.35%-80.68%-856.95%-276.90%-231.43%
EBIT
-33.08-59.55-97.3-89.67-103.48
EBIT Margin
-41.56%-121.00%-1058.44%-348.57%-268.11%
Effective Tax Rate
-0.41%0.00%0.27%0.09%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q